Live news related to IPSEN stock (FR0010259150): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The stock of the French pharmaceutical company traded at 165.20 euros this Wednesday, up 2.99% from the previous day. This increase is part of a susta…
JP Morgan ajuste sa position sur le titre Ipsen ce jeudi 26 mars 2026.
Ipsen has announced the presentation of new preclinical data for two early-stage drug candidates at the American Association of Cancer Research (AACR)…
BNP Paribas Exane modifie ce lundi sa recommandation sur Ipsen.
Ipsen announces the appointment of Michelle C. Werner as the new Executive Vice President (EVP) and President of North America, effective March 23, 20…
Ipsen announces the voluntary and immediate withdrawal of Tazverik (tazemetostat) from all markets where it is sold, across all indications. This deci…
This Friday, Ipsen reached a new historical high at 162.20 euros, surpassing the previous peak achieved the day before. The pharmaceutical company's s…
Ipsen's stock reached an unprecedented peak this Thursday, February 26, surpassing the previous high of 160.80 euros recorded the day before. The phar…
On Wednesday, February 18, 2026, Ipsen's stock reached a new all-time high, hitting €156.80 during the session and surpassing the previous record set …
Deutsche Bank ajuste sa position sur Ipsen ce mardi 17 février 2026.
